Promoter holding
64.27%
AP
Anuh Pharma Limited - Due diligence report
A 360° intelligence report on Anuh Pharma: trust score, financial health, credit view, compliance, directors, growth and distress signals - …
Full Due-Diligence Report + Documents
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
₹700
₹449
Save ₹251
excl. GST
Or from ₹279/report with credits
View credit packages
Company Credits – Starter
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Choose your own credit amount
View credit packages
Anuh Pharma — 360° Intelligence Report
Generated from MCA filings & public records81/100
Trust Score
Low Risk
Anuh Pharma is assessed as Low Risk with a Trust Score of 81/100. Anuh Pharma is an active public limited indian non-government company incorporated in 1960, operating in the Pharma sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a moderate compliance risk and low financial risk profile.
Report generated on 21 Jul 2026 from the latest processed filings. Anuh Pharma Limited snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
02
Score Card
Higher is safer · rule-based & explainableTrust ScoreLow Risk
81/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreModerate
56/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
90/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreLow Risk
95/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
90/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
75/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
90/100
Early-warning signals - higher means fewer warnings.
03
Financial Intelligence Dashboard
Standalone · 5 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
04
Credit & Compliance Intelligence
Why the scores are what they are
Credit Risk Score: 95/100 Low Risk
- Liabilities ≈ 38% EBITDA - serviceable.
- Moderate gearing (D/E 1.42).
- Profitable - internal accruals available.
- Externally credit-rated (A2).
Charges position: 2 open (95.03 cr) · 9 satisfied (112.08 cr).
Banking relationships (from registered charges)
| Lender | Charges | Amount |
|---|---|---|
| Bank Of India | 9 | 48.0 cr |
| Hdfc Bank Limited | 1 | 48.0 cr |
| Canara Bank | 1 | 48.0 cr |
Compliance Score: 56/100 Moderate
- Company status is Active as per MCA.
- Annual filings current (balance sheet Mar 2025).
- Flagged by authority: BSE.
- Litigation present in 2 court forum(s).
- 1 active GST registration(s).
Legal cases on record (2)
05
Director Intelligence
Stability score: 90/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| SIDDHARTH SHAH JASVANTLAL | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| MITA DIXIT | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| SAMIR JAYANTILAL SHAH | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| RITESH BIPIN SHAH | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| VIVEK BIPIN SHAH | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| RITESH BIPIN SHAH | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| GAURAV SATISH SHAH | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| HARMANBHAI TULSHIBHAI PATEL | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| ARUN TODARWAL LALCHAND | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| PRADEEP HARI THAKUR | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| KETAN LALIT SHAH | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| VIVEK BIPIN SHAH | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| Darshan Rampariya | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| BIPIN NEMCHAND SHAH | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| BHARAT NEMCHAND SHAH | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| Manan Jayesh Vadhan | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 16 directors on the board.
- No disqualified or deactivated DINs.
- 2 director exit(s) in the last 3 years.
- Average tenure above 5 years.
Director & KMP remuneration (FY 2023)
| Name | Designation | Total remuneration |
|---|---|---|
| A K Sharma | Managing Director | 2.4 cr |
| R Mehta | Whole-time Director | 1.6 cr |
| S Iyer | CFO | 95.0 L |
Remuneration is disclosed in the latest annual return. Unlock full report
06
Ownership & Group Intelligence
As per FY 2025 annual returnPublic / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
0 allotment(s) · 6 transfer(s)
Promoters hold a minority stake - exact percentages are part of the full report.
Key managerial personnel: RITESH BIPIN SHAH (Managing Director) · VIVEK BIPIN SHAH (CEO) · RITESH BIPIN SHAH (CEO) · VIVEK BIPIN SHAH (Managing Director) · Darshan Rampariya (CFO)
Full shareholding pattern, group structure & capital events →
07
Risk Intelligence Center
Growth 75 · Distress 90
Growth signals & trust indicators
Revenue acceleration: +2.1x over 4 year(s).
EPFO headcount growing - hiring signal.
Operating for 66+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Compliance score is weak (56/100).
2 open charge(s) registered - assets are encumbered.
2 court case(s) on record - see the legal section for details.
08
Stakeholder Verdicts
Vendor · Banker · InvestorVendor due diligence74/100
Favourable indicators
Suitability as a supplier / customer counterparty.
- Check the compliance flags before onboarding.
- No distress signals on file.
- Financial filings available for verification.
Banker assessment84/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
- Debt capacity assessed from filed statements.
- 2 open charge(s) of 95.03 cr already registered.
- Compliance gaps should be priced into terms.
Investor view82/100
Positive growth indicators
Growth quality and scalability through an investor lens.
- 2 growth signal(s) detected.
- Margin and return trends computable from filings.
- Management team looks stable.
09
MCA Filings & Events Timeline
Latest 15 events22 Aug 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
13 May 2024
Director appointed
Manan Jayesh Vadhan (Company Secretary)
01 Apr 2024
Director appointed
SIDDHARTH SHAH JASVANTLAL (Director)
Director appointed
PRADEEP HARI THAKUR (Director)
31 Mar 2024
Director ceased
JASVANTLAL SHAH GIRDHARLAL
17 Aug 2023
Director ceased
GAURAV SATISH SHAH
01 Jul 2023
Director appointed
GAURAV SATISH SHAH (Director)
10 Feb 2023
Director ceased
LALIT POPATLAL SHAH
08 Jan 2021
Director ceased
RITESH BIPIN SHAH
Director ceased
VIVEK BIPIN SHAH
07 Jan 2021
Director ceased
BIPIN NEMCHAND SHAH
31 Mar 2020
Share transfer (FY 2020)
1800.00000000 shares to Dhudalal Shah
22 Aug 2019
Director ceased
HARMANBHAI TULSHIBHAI PATEL
22 May 2019
Director appointed
HARMANBHAI TULSHIBHAI PATEL (Director)
10
Key Observations
Auto-generated from the data aboveRevenue grew 24% over the last 4 financial year(s).
Net profit margin moved from 0.86 to 61%.
Debt-to-equity stands at 38% - manageable leverage.
Net worth is positive.
16 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
Carries an external credit rating of A2 from Icra.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a minority stake as per the FY 2025 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
| Company | CIN | Location |
|---|---|---|
| Aarti Surfactants | L24100MP2018PLC067037 | Dhar, Madhya Pradesh, India |
| Ultramarine & Pigments | L24224MH1960PLC011856 | Mumbai, Maharashtra, India |
| Rpg Life Sciences | L24232MH2007PLC169354 | Mumbai, Maharashtra, India |
| Mpl | L24294TN1986PLC013087 | Chennai, Tamil Nadu, India |
| Sree Rayalaseema Hi-Strength H | L24110AP2005PLC045726 | Kurnool Dist, Andhra Pradesh, India |
| Transpek | L23205GJ1965PLC001343 | Vadodara, Gujarat, India |
| Yasho Industries | L74110MH1985PLC037900 | Mumbai, Maharashtra, India |
| Kanoria Chemicals & Industries | L24110WB1960PLC024910 | Kolkata, West Bengal, India |
12
Who Uses This Report
CA · CS · Banker · Investor · VendorChartered Accountants (CA)
Verify Anuh Pharma before audits and certifications: compliance score 56/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Company Secretaries (CS)
Track statutory health of Anuh Pharma: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Bankers & NBFCs
Current banker verdict: Favourable lending indicators. Credit risk score 95/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investors & Analysts
Investor view: Positive growth indicators. Growth score 75/100, margin trends, ownership structure and peer set for Anuh Pharma - screening before a deeper diligence.
Vendors & Procurement Teams
Vendor verdict: Favourable indicators. Trust score 81/100, distress signals and MSME payment-delay disclosures - know whether Anuh Pharma pays its suppliers before you extend credit terms.
Lawyers & Compliance Teams
Litigation footprint (2 case(s) on record), regulatory flags, charge documents trail and director networks for Anuh Pharma - groundwork for KYC, onboarding and disputes.
13
Frequently Asked Questions
Is Anuh Pharma an active company?
Anuh Pharma has MCA status “Active” with a compliance score of 56/100 (Moderate).
Is Anuh Pharma financially healthy?
Anuh Pharma has a Financial Health Score of 90/100 (Low Risk) based on its filed financial statements.
Should I do business with Anuh Pharma?
Its overall Trust Score is 81/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Anuh Pharma?
Promoters hold a minority stake - exact percentages are in the full report. 16 active director(s) are on record.
Does Anuh Pharma have loans or charges against its assets?
2 open charge(s) are registered against its assets, and 9 earlier charge(s) stand satisfied.
Is Anuh Pharma up to date with its ROC filings?
Annual filings current (balance sheet Mar 2025). Overall compliance score: 56/100 (Moderate).
Is it risky to lend to Anuh Pharma?
Its Credit Risk Score is 95/100 (Low Risk). Banker verdict: Favourable lending indicators.
Disclaimer: This report is generated automatically from MCA filings and public records as available
in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the
underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are
not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice.
Verify from official sources and consult a qualified professional before any business, lending or investment decision.
If you represent this company and believe any information is inaccurate or outdated,
report it here and we will review promptly.
